VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI – Trademark Portfolio
Entity Type: 99
VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include VSY BIOTECHNOLOGY ENOVATION TECHNOLOGY and VSY BIOTECHNOLOGY SVT SINUSOIDAL SINUSOIDAL VISION TECHNOLOGY. The owner is based in Tuzla - Istanbul.
Istanbul Tuzla Organize Sanayi Bölgesi
Tuzla - Istanbul , TR
Showing of trademarks Trademarks
Trademark Classifications
VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI have?
VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI file in?
VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI's most well-known trademarks?
VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI's registered trademark portfolio includes well-known marks such as VSY BIOTECHNOLOGY ENOVATION TECHNOLOGY and VSY BIOTECHNOLOGY SVT SINUSOIDAL SINUSOIDAL VISION TECHNOLOGY. These are among 2 currently registered trademarks in the portfolio.
What is VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI's trademark registration success rate?
VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.